Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Purchase track record

Not enough history. Based on 1 purchase with a full 90 days of price history.

—
Avg. 90-day return+0.7%
vs. S&P 500-11.1%
Beat the market0%
Paper profit on buys−$67K
Total bought / sold$498K / $661K

Reported trades

Filed Stock Type Shares Price Value Since
Mar 3SEC MYNBlackrock Muniyield New York Quality Fund, Inc. Buy 49,025new position $10.15 $498K -13.4%
Dec 22SEC BMEZBlackRock Health Sciences Term Trust Sell 10,2940 held (−100%) $14.98 $154K +10.3%
Dec 22SEC BMEZBlackRock Health Sciences Term Trust Sell 0 $14.96 $6 +10.4%
Dec 22SEC BMEZBlackRock Health Sciences Term Trust Sell 10,2940 held (−100%) $14.98 $154K +10.3%
Dec 22SEC BMEZBlackRock Health Sciences Term Trust Sell 0 $14.96 $6 +10.4%
Dec 22SEC BTXBlackRock Technology & Private Equity Term Trust Sell 21,9361 held (−100%) $6.52 $143K +44.2%
Dec 22SEC BTXBlackRock Technology & Private Equity Term Trust Sell 1 $6.55 $5 +43.5%
Dec 22SEC BSTZBlackRock Science & Technology Term Trust Sell 9,2931 held (−100%) $22.51 $209K +33.7%
Dec 22SEC BSTZBlackRock Science & Technology Term Trust Sell 1 $22.73 $15 +32.4%
  • Buy

    Director Robert W Fairbairn bought $498K of MYN at $10.15 — first open-market purchase in our records; opens a new position.

  • Sell

    Director Robert W Fairbairn sold $154K of BMEZ at $14.98 — cuts the stake by 100%.

  • Sell

    Director Robert W Fairbairn sold $154K of BMEZ at $14.98 — cuts the stake by 100%.

  • Sell

    Director Robert W Fairbairn sold $143K of BTX at $6.52 — cuts the stake by 100%.

  • Sell

    Director Robert W Fairbairn sold $209K of BSTZ at $22.51 — cuts the stake by 100%.